Funding for this research was provided by:
National Institutes of Health (CA198999)
Jilin Provincial Health and Family Planning Commission (2020Q012)
Fundamental Research Funds for the Central Universities (N/A)
National Natural Science Foundation of China (81774240, 81403272)
China Scholarship Council (201808310047)
Shanghai Rising-Star Program (17QA1403900)
Talents Cultivation Program of Jilin University (N/A)
Chenguang Program from Shanghai Education Development Foundation and Shanghai Municipal Education Commission (15CG48)
Training Plan of Outstanding Young Medical Talents from Shanghai Municipal Health Bureau (2017YQ021)
Talent Youth Supporting Project from Chinese Medicine Association (QNRC2-C14)
Received: 20 October 2020
Accepted: 17 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: The procedures used in this study were approved by Institutional Animal Care and Use Committee of University of North Carolina at Chapel Hill and by the Animal Ethics Committee of Jilin University.
: Not applicable.
: LH is a consultant of PDS Biotechnology, Samyang Biopharmaceutical Co, Stemirna and Beijing Inno Medicine. All other co-authors declare no conflict.